This compound is an N-protected derivative of L-glutamic acid, featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ester. It is primarily used as a building block in solid-phase peptide synthesis.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 84793-07-7
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid
Fmoc-protected aspartic acid derivative
(S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid
Fmoc-protected amino acid derivative
4-(Dimethylamino)-2-butenoic acid hydrochloride
Pharmaceutical intermediate for API synthesis
N-(3-Cyano-7-ethoxy-4-hydroxyquinolin-6-yl)acetamide
pharmaceutical intermediate
N-(4-CHLORO-3-CYANO-7-ETHOXY-6-QUINOLINYL)ACETAMIDE
Pharmaceutical intermediate
4-{[3-(4-acetylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate
(4R)-5-(tert-butoxy)-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid
Fmoc-protected amino acid derivative
(4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid
GOPWHXPXSPIIQZ-FQEVSTJZSA-N
CC(C)(C)OC(=O)[C@H](CCC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13